Matches in Nanopublications for { ?s ?p "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- NP638830.RAsCp7RiiLA8QAYydwOq41Nj8Jqg0AUpyoIS6rscYBMLI130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638830.RAsCp7RiiLA8QAYydwOq41Nj8Jqg0AUpyoIS6rscYBMLI130_provenance.
- NP374203.RAAg2heabAWx4WVJCaxn3TAR0gWDfeFn6gKFWISyClEas130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374203.RAAg2heabAWx4WVJCaxn3TAR0gWDfeFn6gKFWISyClEas130_provenance.
- NP390052.RA5fo-de33XBiCHwATi1lpL-5P9eRDB8KpWZ8-_Xop5D8130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390052.RA5fo-de33XBiCHwATi1lpL-5P9eRDB8KpWZ8-_Xop5D8130_provenance.
- NP390055.RA25TT04UjO9dHdRJdKs8n_HvLHPny7x9G49rEvRFKyYg130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390055.RA25TT04UjO9dHdRJdKs8n_HvLHPny7x9G49rEvRFKyYg130_provenance.
- NP390289.RAzqIDMUIG7bdxuNVVtnQ9ODy40m1O4kjy-zbtnW3kXdQ130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390289.RAzqIDMUIG7bdxuNVVtnQ9ODy40m1O4kjy-zbtnW3kXdQ130_provenance.
- NP920438.RAOsCgnloEKUf0B0y-nE3Xn_aNZaStpQFUU-EwaaRPS3U130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP920438.RAOsCgnloEKUf0B0y-nE3Xn_aNZaStpQFUU-EwaaRPS3U130_provenance.
- NP515715.RADM_VvL4cFfzyN9IzgPTqcWcOaRNF1b6hF7F-YjLkN40130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515715.RADM_VvL4cFfzyN9IzgPTqcWcOaRNF1b6hF7F-YjLkN40130_provenance.
- NP885461.RALnqov0nsbJJv6-iu7qzWpkpuXWBWdzyAazmfwsStZOI130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885461.RALnqov0nsbJJv6-iu7qzWpkpuXWBWdzyAazmfwsStZOI130_provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP943737.RAamxffvkNqNFRPYakzX7Qo-xmYUUbVphkcCWtJcvlFgg130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943737.RAamxffvkNqNFRPYakzX7Qo-xmYUUbVphkcCWtJcvlFgg130_provenance.
- NP943865.RAW7S73F49WWkNvKxNDDLG58FnDVIZEFTYEuxHjAVWGbc130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943865.RAW7S73F49WWkNvKxNDDLG58FnDVIZEFTYEuxHjAVWGbc130_provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP808781.RASgcPxsrAVUOZMaebiYNR4gTJ5pj5lKkHerDYd_beRf8130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808781.RASgcPxsrAVUOZMaebiYNR4gTJ5pj5lKkHerDYd_beRf8130_provenance.
- NP809152.RAQQFs2N6VfuC8hSqVPJEyYzPcny67-nhUlK_-VEr2gYY130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809152.RAQQFs2N6VfuC8hSqVPJEyYzPcny67-nhUlK_-VEr2gYY130_provenance.
- NP974445.RAWeO3O63nvqPoYKyDGQ2Vm0sOwKjmpBvIHyr3O7SnFdg130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974445.RAWeO3O63nvqPoYKyDGQ2Vm0sOwKjmpBvIHyr3O7SnFdg130_provenance.
- NP974446.RARrrS-DYbGKGch2js2GYBL9KXrZzTfADCRWpy0dcJ320130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974446.RARrrS-DYbGKGch2js2GYBL9KXrZzTfADCRWpy0dcJ320130_provenance.
- NP974566.RAQ33jgblPJHV7DW-bUi1LAsW5os47ZIkyUO-6iIB3NR0130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP974566.RAQ33jgblPJHV7DW-bUi1LAsW5os47ZIkyUO-6iIB3NR0130_provenance.
- NP515721.RA25K-RuGHNS8i_-buQy97bEwj7SFpsX1xKSxy2XriUgI130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515721.RA25K-RuGHNS8i_-buQy97bEwj7SFpsX1xKSxy2XriUgI130_provenance.
- NP515722.RA3mZoBOXhhxflicGmMR-MBvZurQpruDIvepKpGLhOekw130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515722.RA3mZoBOXhhxflicGmMR-MBvZurQpruDIvepKpGLhOekw130_provenance.
- NP515724.RA7RghkrYVNwQcpiCStqmIif8nWGY65woOAgU0_pMHpLw130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515724.RA7RghkrYVNwQcpiCStqmIif8nWGY65woOAgU0_pMHpLw130_provenance.
- NP515711.RA-bc_WuUT3Am9F9CAQc5heZr3TDAw5dhHqOeSn01T0g0130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515711.RA-bc_WuUT3Am9F9CAQc5heZr3TDAw5dhHqOeSn01T0g0130_provenance.
- NP515712.RA-Bb0G5u28hth0WfEQBi3juQZhl2XonpbNXlUCWZaG7o130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515712.RA-Bb0G5u28hth0WfEQBi3juQZhl2XonpbNXlUCWZaG7o130_provenance.
- NP515719.RA13jV7adYJOGmlf1VP2ekAdLKQ2PETmnqSxhYDEnRkP4130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515719.RA13jV7adYJOGmlf1VP2ekAdLKQ2PETmnqSxhYDEnRkP4130_provenance.
- NP373980.RAH-qosXCcLTTo_3-iniqu5D2crpy_FKgEodkEMkKNAXk130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373980.RAH-qosXCcLTTo_3-iniqu5D2crpy_FKgEodkEMkKNAXk130_provenance.
- NP515710.RAf4Q5hgz5vxsjFCl6B2ksyiJeu4EGRD1jgGVQEHOQhvc130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515710.RAf4Q5hgz5vxsjFCl6B2ksyiJeu4EGRD1jgGVQEHOQhvc130_provenance.
- NP515713.RAXZudGSLGo3VIhMjUKc931aS9SnNLjpXoupLje377lko130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515713.RAXZudGSLGo3VIhMjUKc931aS9SnNLjpXoupLje377lko130_provenance.
- NP515714.RAUNxU--xFNky_q-i3QEcsWotLJM0VInZIc0q2uf7DV8M130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515714.RAUNxU--xFNky_q-i3QEcsWotLJM0VInZIc0q2uf7DV8M130_provenance.
- NP515720.RAfngw8EU5WD6wrZohg1d_AsCohyoy7XqoG_udhS0e27A130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515720.RAfngw8EU5WD6wrZohg1d_AsCohyoy7XqoG_udhS0e27A130_provenance.
- NP808782.RAL1Ygvo1TPQU6qHxVNQjKZvCR_TwUOtIHJJpxEhNExCA130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808782.RAL1Ygvo1TPQU6qHxVNQjKZvCR_TwUOtIHJJpxEhNExCA130_provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP515716.RAKTlpVzg125omWVNZIelloLtB67Bu0yLvzzMZD4VGqJg130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515716.RAKTlpVzg125omWVNZIelloLtB67Bu0yLvzzMZD4VGqJg130_provenance.
- NP515718.RAE086NeocesKJJQhsi6GJvgYKEMyerbqDrSNWoEMUN3w130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515718.RAE086NeocesKJJQhsi6GJvgYKEMyerbqDrSNWoEMUN3w130_provenance.
- NP515723.RAOscQJi7WBePIOHTLMrYEcfKbd7IHSqWIOO3xuqUGgiE130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515723.RAOscQJi7WBePIOHTLMrYEcfKbd7IHSqWIOO3xuqUGgiE130_provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP373981.RAjw2sJB4H1zceZDbOnEwtNMFLqRcYroTg_3-Z43vm1Hs130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373981.RAjw2sJB4H1zceZDbOnEwtNMFLqRcYroTg_3-Z43vm1Hs130_provenance.
- NP943736.RAqh4HT5Dg-klUBHkOkJWL3fKPveOzU5g8rwxxH3Ucx7Q130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943736.RAqh4HT5Dg-klUBHkOkJWL3fKPveOzU5g8rwxxH3Ucx7Q130_provenance.
- NP515709.RAtzrfgesUWElXtp6a6CBiKUqeZ-XSARYRxeyWiw2hXC0130_assertion description "[PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515709.RAtzrfgesUWElXtp6a6CBiKUqeZ-XSARYRxeyWiw2hXC0130_provenance.